Finance

Lists
Why is GTBP down 2,67%?
Dive Deeper
GTBP:NASDAQ
GT Biopharma Inc
6,20 US$
-2,67%
(-0,17) 1D
6,32 US$
+1,94% (+0,12)
After hours
Closed: 7 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GTBP...
Open
6,30 US$
High
6,47 US$
Low
6,20 US$
Mkt. cap
11,19 მლნ.
Avg. vol.
237,06 ათ.
Volume
0,00
52-wk high
34,25 US$
52-wk low
4,91 US$
EPS
-35,41 US$
Beta
0,86
Shares outstanding
2,06 მლნ.
No. of employees
1
Open
6,30 US$
High
6,47 US$
Low
6,20 US$
Mkt. cap
11,19 მლნ.
Avg. vol.
237,06 ათ.
Volume
0,00
52-wk high
34,25 US$
52-wk low
4,91 US$
EPS
-35,41 US$
Beta
0,86
Shares outstanding
2,06 მლნ.
No. of employees
1
News stories
From web sources and news partners
About GT Biopharma Inc
CEO-
Employees1
Founded1965
Headquartersსან-ფრანცისკო, კალიფორნია, ამერიკის შეერთებული შტატები
Sector-
Websitegtbiopharma.com
Analyst ratings
Based on 1 analyst giving stock ratings to GTBP in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for GTBP in the last 3 months
Highest
Current 6,20 US$
3,00 US$ (-51,61%)
Average
3,00 US$ (-51,61%)
Lowest
3,00 US$ (-51,61%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jonathan Aschoff
Roth MKM
Buy
Maintained
3,00 US$
-51,6%
08/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
634,00 ათ.
1,38 მლნ.
413,00 ათ.
1,06 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,75 მლნ.
4,22 მლნ.
2,44 მლნ.
3,46 მლნ.
Operating expense
3,38 მლნ.
5,60 მლნ.
2,85 მლნ.
4,51 მლნ.
Total operating expenses
3,38 მლნ.
5,60 მლნ.
2,85 მლნ.
4,51 მლნ.
Operating income
-3,38 მლნ.
-5,60 მლნ.
-2,85 მლნ.
-4,51 მლნ.
Other non operating income
232,00 ათ.
-17,33 მლნ.
11,00 ათ.
-
EBT including unusual items
-3,11 მლნ.
-23,03 მლნ.
-2,83 მლნ.
-4,52 მლნ.
EBT excluding unusual items
-3,11 მლნ.
-23,03 მლნ.
-2,83 მლნ.
-4,52 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,11 მლნ.
-23,03 მლნ.
-2,83 მლნ.
-4,52 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
36,00 ათ.
17,00 ათ.
67,00 ათ.
58,00 ათ.
Interest expense
-
-127,00 ათ.
-63,00 ათ.
-64,00 ათ.
Net interest expenses
36,00 ათ.
-110,00 ათ.
4,00 ათ.
-6,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები